148 related articles for article (PubMed ID: 27457783)
1. Bioactivation of Trimethoprim to Protein-Reactive Metabolites in Human Liver Microsomes.
Goldman JL; Koen YM; Rogers SA; Li K; Leeder JS; Hanzlik RP
Drug Metab Dispos; 2016 Oct; 44(10):1603-7. PubMed ID: 27457783
[TBL] [Abstract][Full Text] [Related]
2. Urinary biomarkers of trimethoprim bioactivation in vivo following therapeutic dosing in children.
van Haandel L; Goldman JL; Pearce RE; Leeder JS
Chem Res Toxicol; 2014 Feb; 27(2):211-8. PubMed ID: 24380396
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Hepatic Oxidative Biotransformation of Trimethoprim.
Goldman JL; Leeder JS; Van Haandel L; Pearce RE
Drug Metab Dispos; 2015 Sep; 43(9):1372-80. PubMed ID: 26138612
[TBL] [Abstract][Full Text] [Related]
4. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection.
Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP
Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of bioactivation and covalent binding of 2,4,6-trinitrotoluene.
Leung KH; Yao M; Stearns R; Chiu SH
Chem Biol Interact; 1995 Jun; 97(1):37-51. PubMed ID: 7767940
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim: novel reactive intermediates and bioactivation pathways by cytochrome p450s.
Damsten MC; de Vlieger JS; Niessen WM; Irth H; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2008 Nov; 21(11):2181-7. PubMed ID: 18816075
[TBL] [Abstract][Full Text] [Related]
7. Screening Trimethoprim Primary Metabolites for Covalent Binding to Albumin.
Nolte WM; Tessman RT; Goldman JL
Med Chem Res; 2020 Jul; 29(7):1238-1246. PubMed ID: 33584083
[TBL] [Abstract][Full Text] [Related]
8. Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells.
Summan M; Cribb AE
Chem Biol Interact; 2002 Nov; 142(1-2):155-73. PubMed ID: 12399161
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of trimethoprim to a reactive iminoquinone methide by activated human neutrophils and hepatic microsomes.
Lai WG; Zahid N; Uetrecht JP
J Pharmacol Exp Ther; 1999 Oct; 291(1):292-9. PubMed ID: 10490916
[TBL] [Abstract][Full Text] [Related]
10. Trimethoprim-sulfamethoxazole-induced hyponatremia.
Dunn RL; Smith WJ; Stratton MA
Consult Pharm; 2011 May; 26(5):342-9. PubMed ID: 21733815
[TBL] [Abstract][Full Text] [Related]
11. Trimethoprim/sulfamethoxazole-induced tremor in a patient with AIDS.
Slavik RS; Rybak MJ; Lerner SA
Ann Pharmacother; 1998 Feb; 32(2):189-92. PubMed ID: 9496403
[TBL] [Abstract][Full Text] [Related]
12. Characterization of in vitro metabolites of trimethoprim and diaveridine in pig liver microsomes by liquid chromatography combined with hybrid ion trap/time-of-flight mass spectrometry.
Liu ZY; Wu Y; Sun ZL; Wan L
Biomed Chromatogr; 2012 Sep; 26(9):1101-8. PubMed ID: 22161732
[TBL] [Abstract][Full Text] [Related]
13. Bioactivation of phenytoin by human cytochrome P450: characterization of the mechanism and targets of covalent adduct formation.
Munns AJ; De Voss JJ; Hooper WD; Dickinson RG; Gillam EM
Chem Res Toxicol; 1997 Sep; 10(9):1049-58. PubMed ID: 9305589
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes.
Sawahata T; Neal RA
Mol Pharmacol; 1983 Mar; 23(2):453-60. PubMed ID: 6835203
[TBL] [Abstract][Full Text] [Related]
16. In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinone type metabolites.
Zhang Z; Chen Q; Li Y; Doss GA; Dean BJ; Ngui JS; Silva Elipe M; Kim S; Wu JY; Dininno F; Hammond ML; Stearns RA; Evans DC; Baillie TA; Tang W
Chem Res Toxicol; 2005 Apr; 18(4):675-85. PubMed ID: 15833027
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.
Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK
J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient.
Roustit M; Blondel E; Villier C; Fonrose X; Mallaret MP
Ann Pharmacother; 2010 Apr; 44(4):764-7. PubMed ID: 20197475
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the NADPH-dependent covalent binding of [14C]halothane to human liver microsomes: a role for cytochrome P4502E1 at low substrate concentrations.
Madan A; Parkinson A
Drug Metab Dispos; 1996 Dec; 24(12):1307-13. PubMed ID: 8971135
[TBL] [Abstract][Full Text] [Related]
20. Effect of standard-dose trimethoprim/sulfamethoxazole on the serum potassium concentration in elderly men.
Witt JM; Koo JM; Danielson BD
Ann Pharmacother; 1996 Apr; 30(4):347-50. PubMed ID: 8729886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
